EUS-guided choledochoduodenostomy for malignant biliary obstruction: A multicenter comparative study between plastic and metallic stents

Nenhuma Miniatura disponível
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WOLTERS KLUWER MEDKNOW PUBLICATIONS
Citação
ENDOSCOPIC ULTRASOUND, v.12, n.1, p.120-127, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and Objectives: EUS-guided choledochoduodenostomy (EUS-CDS) is commonly employed to address malignant biliary obstruction (MBO) after a failed ERCP. In this context, both self-expandable metallic stents (SEMSs) and double-pigtail stents (DPSs) are suitable devices. However, few data comparing the outcomes of SEMS and DPS exist. Therefore, we aimed to compare the efficacy and safety of SEMS and DPS at performing EUS-CDS. Methods: We conducted a multicenter retrospective cohort study between March 2014 and March 2019. Patients diagnosed with MBO were considered eligible after at least one failed ERCP attempt. Clinical success was defined as a drop of direct bilirubin levels >= 50% at 7 and 30 postprocedural days. Adverse events (AEs) were categorized as early (<= 7 days) or late (> 7 days). The severity of AEs was graded as mild, moderate, or severe. Results: Forty patients were included, 24 in the SEMS group and 16 in the DPS group. Demographic data were similar between the groups. Technical success rates and clinical success rates at 7 and 30 days were similar between the groups. Similarly, we found no statistical difference in the incidence of early or late AEs. However, there were two severe AEs (intracavitary migration) in the DPS group and none in the SEMS cohort. Finally, there was no difference in median survival (DPS 117 days vs. SEMS 217 days; P = 0.99). Conclusion: EUS-guided CDS is an excellent alternative to achieve biliary drainage after a failed ERCP for MBO. There is no significant difference regarding the effectiveness and safety of SEMS and DPS in this context.
Palavras-chave
biliary drainage, EUS, endoscopic, jaundice, stent
Referências
  1. Adler DG, 2005, GASTROINTEST ENDOSC, V62, P1, DOI 10.1016/j.gie.2005.04.015
  2. Bang JY, 2018, GASTROINTEST ENDOSC, V88, P9, DOI 10.1016/j.gie.2018.03.012
  3. Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027
  4. Artifon ELD, 2019, ENDOSC ULTRASOUND, V8, pS72, DOI 10.4103/eus.eus_62_19
  5. Visconti TAD, 2018, ENDOSC INT OPEN, V6, pE914, DOI 10.1055/a-0626-7048
  6. Dhindsa BS, 2020, ENDOSC ULTRASOUND, V9, P101, DOI 10.4103/eus.eus_80_19
  7. Fujisawa T, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-161
  8. Guo JT, 2018, ENDOSC ULTRASOUND, V7, P356, DOI 10.4103/eus.eus_53_18
  9. Gupta K, 2014, J CLIN GASTROENTEROL, V48, P80, DOI 10.1097/MCG.0b013e31828c6822
  10. Hedjoudje A, 2019, UNITED EUR GASTROENT, V7, P60, DOI 10.1177/2050640618808147
  11. Khashab MA, 2016, ENDOSC INT OPEN, V4, pE175, DOI 10.1055/s-0041-109083
  12. Khashab MA, 2015, GASTROINTEST ENDOSC, V82, P993, DOI 10.1016/j.gie.2015.06.043
  13. KOYAMA K, 1981, AM J SURG, V142, P293, DOI 10.1016/0002-9610(81)90296-8
  14. Krishnamoorthi R, 2020, SURG ENDOSC, V34, P2866, DOI 10.1007/s00464-020-07484-w
  15. Logiudice FP, 2019, WORLD J GASTRO ENDOS, V11, P281, DOI 10.4253/wjge.v11.i4.281
  16. Mohan BP, 2019, J CLIN GASTROENTEROL, V53, P243, DOI 10.1097/MCG.0000000000001167
  17. Péus D, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-72
  18. Salerno R, 2019, WORLD J GASTRO ENDOS, V11, P354, DOI 10.4253/wjge.v11.i5.354
  19. Schmidt A, 2015, ENDOSCOPY, V47, P430, DOI 10.1055/s-0034-1391232
  20. Tag CG, 2015, LAB ANIM-UK, V49, P70, DOI 10.1177/0023677214567748
  21. Tarantino I, 2021, ENDOSC INT OPEN, V09, pE110, DOI 10.1055/a-1313-6850
  22. Teoh AYB, 2018, GUT, V67, P1209, DOI 10.1136/gutjnl-2017-314341
  23. Wang KX, 2016, GASTROINTEST ENDOSC, V83, P1218, DOI 10.1016/j.gie.2015.10.033
  24. Worku MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227135